Clinical Watch List

Sepsis, the body’s extreme response to infection, remains a significant health concern globally. In the context of MDROs, bacterial agents like E. coli and Klebsiella spp. force difficult decision-making in healthcare settings. For these challenging infections, timely and accurate antimicrobial susceptibility testing (AST) plays a crucial role in determining the right antimicrobials to kill the bacteria or stop it from spreading, thereby helping the body’s natural immune system to fight the infection that causes severe sepsis.

In this white paper, we take a look at the critical role of AST in guiding antibiotic therapy, different methodologies, and best practices to enhance laboratory accuracy and communication.

Every minute counts when MDROs can cause healthcare-associated infections (HAIs) – infections patients acquire during healthcare treatment. These infections can quickly spiral out of control and become costly and deadly emergencies. Labs and clinicians make consequential decisions each and every day as pathogens, such as MRSA, Acinetobacter baumannii and Clostridioides difficile, become more prevalent and present greater risks to patients and hospital operations.

But while clinicians and labs may feel the odds are stacked against them in preventing MDROs and the dangerous and costly HAIs they can cause, there is hope. Let's explore the new tools, techniques, and clinical perspectives that can help even the score.